Utilization and Outcomes of Multigene Panel Testing in Patients With Pancreatic Ductal Adenocarcinoma.
Derk C F KlatteJason S StarrKristin E CliftHeather D HardwayJeanin E van HooftMonique E van LeerdamThomas P PotjerRichard John PresuttiDouglas L Riegert-JohnsonMichael B WallaceYan BiPublished in: JCO oncology practice (2024)
GT remains underutilized despite National Comprehensive Cancer Network guideline recommendations. Given the poor prognosis of PDAC and potential implications of GT, efforts to increase utilization are needed to provide surveillance and support to both patients with PDAC and at-risk family members.